February 28, 2018 / 1:14 PM / 8 months ago

BRIEF-Pacira Pharmaceuticals Reports Q4 GAAP EPS Of $0.11

Feb 28 (Reuters) - Pacira Pharmaceuticals Inc:

* PACIRA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 NON-GAAP EARNINGS PER SHARE $0.38

* Q4 REVENUE ROSE 8 PERCENT TO $79.1 MILLION

* SEES ‍ 2018 EXPAREL NET PRODUCT SALES OF $300 MILLION TO $310 MILLION​

* SEES ‍ 2018 NON-GAAP GROSS MARGINS OF 70% TO 72%​

* SEES ‍ 2018 NON-GAAP RESEARCH AND DEVELOPMENT EXPENSE OF $50 MILLION TO $60 MILLION​

* Q4 EARNINGS PER SHARE VIEW $0.10, REVENUE VIEW $79.3 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below